The Future of MS Management: Novel Agents and Clinical Approaches
- Author
- ReachMD
- Published
- Tue 26 Aug 2025
- Episode Link
- http://reachmd.com/programs/neurofrontiers/program-name/36360/
Guest: Marisa McGinley, DO
The multiple sclerosis (MS) treatment landscape is rapidly evolving, with novel approaches on the horizon that may transform care for progressive patients. Explore the latest phase 3 data on BTK inhibitors like tolebrutinib and gain insights into ongoing CAR T-cell and remyelination research, including the BEAT-MS trial, with Dr. Marisa McGinley, a neurologist at the Cleveland Clinic.
